Literature DB >> 28674852

Effects of long-term treatment with haloperidol, clozapine and aripiprazole on mice isolated vas deferens.

Mehmet Hanifi Tanyeri1, Mehmet Emin Buyukokuroglu2, Pelin Tanyeri3, Oguz Mutlu4, Füruzan Yildiz Akar4, Güner Ulak4, Bekir Faruk Erden4.   

Abstract

PURPOSE: Sexual dysfunction is a common condition in patients taking antipsychotics and is the most bothersome symptom and adverse drug effect, resulting in a negative effect on treatment compliance. Pharmacology research into human ejeculatory disorders is limited to clinical studies with registered drugs affecting the ejaculation process; therefore, animal research has become the need. We aimed to investigate the effects of haloperidol, clozapine and aripiprazole on serotonin, noradrenaline, adenosine triphosphate (ATP) and potassium chloride (KCl)-induced contractions of the vas deferens in order to evaluate the effect of haloperidol, clozapine and aripiprazole on the contraction of the vas deferens.
METHODS: Male inbred BALB/c ByJ mice aged 7 weeks upon arrival to the laboratory were used in this study. Haloperidol, clozapine, aripiprazole, serotonin, noradrenaline, ATP and KCl were dissolved in 0.9% physiological saline. The mice were randomly divided into experimental groups as follows: saline; haloperidol 0.125 mg/kg; haloperidol 0.25 mg/kg; clozapine 1.25 mg/kg; clozapine 2.5 mg/kg; aripiprazole 3 mg/kg; aripiprazole 6 mg/kg. Mice were treated by ip injection of drugs during 21 days. Mice receiving only the vehicle ip (0.9% saline) during 21 days served as control group (n = 7). Each experimental group consisted of 7 mice. After 21 days of treatment, epididymal and prostatic portions of vas deferens were surgically dissected free and immersed in 20-mL organ baths containing Krebs' solution. The effects of chronic treatment with haloperidol (0.125 and 0.25 mg/kg), clozapine(1.25 and 2.5 mg/kg) and aripiprazole (3 and 6 mg/kg) were investigated on serotonin [10 (-8) to 10 (-4) M], noradrenaline [10 (-8) to 10 (-4) M], ATP [10 (-8) to 10 (-4) M] and 80 mM KCl-induced contractile responses in the epididymal and prostatic portions of mice isolated vas deferens strips. Statistical comparison between the groups was performed using ANOVA supported by Dunnett's post hoc test.
RESULTS: Serotonin-induced contractile responses were significantly increased in the epididymal and prostatic portions of the vas deferens obtained from the haloperidol-treated group and clozapine-treated group. However, aripiprazole treatment had no effect on serotonin responses in both epididymal and prostatic portions of mice vas deferens. On the other hand, haloperidol and clozapine treatments significantly inhibited both noradrenaline and ATP-induced contractions of the prostatic and epididymal portions of the mice vas deferens, but had no effect on KCl-induced contractions of the vas deferens in both portions. There were no significant differences in KCl-induced contractile responses among the groups.
CONCLUSIONS: These results revealed that induced contractions of vas deferens were affected after chronic treatment with haloperidol and clozapine but not aripiprazole. Serotonergic, noradrenergic and purinergic receptors may, at least in part, contribute to changes in vas deferens contractions in mice with chronic treatment of haloperidol and clozapine but not aripiprazole.

Entities:  

Keywords:  Aripiprazole; Clozapine; Haloperidol; Organ bath

Mesh:

Substances:

Year:  2017        PMID: 28674852     DOI: 10.1007/s11255-017-1640-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  33 in total

1.  Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea-pig.

Authors:  P Sneddon; M Machaly
Journal:  J Auton Pharmacol       Date:  1992-12

Review 2.  Sexual side-effects of antidepressant and antipsychotic drugs.

Authors:  Angel L Montejo; Laura Montejo; Felipe Navarro-Cremades
Journal:  Curr Opin Psychiatry       Date:  2015-11       Impact factor: 4.741

3.  Long-term treatment with fluoxetine associates with peripheral effects on rat vas deferens contractility.

Authors:  L Busch; M Wald; E Borda
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 4.  Sexuality and schizophrenia: a review.

Authors:  Deanna L Kelly; Robert R Conley
Journal:  Schizophr Bull       Date:  2004       Impact factor: 9.306

5.  Involvement of serotonin receptor subtypes in the antidepressant-like effect of beta receptor agonist Amibegron (SR 58611A): an experimental study.

Authors:  Pelin Tanyeri; Mehmet Emin Buyukokuroglu; Oguz Mutlu; Güner Ulak; Füruzan Yıldız Akar; Ipek Komsuoglu Celikyurt; Bekir Faruk Erden
Journal:  Pharmacol Biochem Behav       Date:  2013-02-01       Impact factor: 3.533

6.  Antipsychotic-induced sexual dysfunction and its management.

Authors:  Yeon Won Park; Yooseok Kim; Jun Ho Lee
Journal:  World J Mens Health       Date:  2012-12-27       Impact factor: 5.400

7.  Effect of calcium antagonists on the response to noradrenaline in the whole and bisected rat vas deferens.

Authors:  C Boselli; L Bianchi; A Barbieri; E Grana
Journal:  J Auton Pharmacol       Date:  1998-10

Review 8.  Central neurophysiology and dopaminergic control of ejaculation.

Authors:  Magali Peeters; François Giuliano
Journal:  Neurosci Biobehav Rev       Date:  2007-09-01       Impact factor: 8.989

9.  Fluoxetine-induced inhibition of male rat copulatory behavior: modification by lesions of the nucleus paragigantocellularis.

Authors:  D P Yells; M A Prendergast; S E Hendricks; M Nakamura
Journal:  Pharmacol Biochem Behav       Date:  1994-09       Impact factor: 3.533

10.  Change in sexual dysfunction with aripiprazole: a switching or add-on study.

Authors:  Amna Mir; Kuppuswami Shivakumar; Richard J Williamson; Victoria McAllister; Veronica O'Keane; Katherine J Aitchison
Journal:  J Psychopharmacol       Date:  2008-05       Impact factor: 4.153

View more
  1 in total

1.  Deficiency of MTMR14 impairs male fertility in Mus musculus.

Authors:  Nana Wen; Meng-Fei Yu; Jing Liu; Congli Cai; Qing-Hua Liu; Jinhua Shen
Journal:  PLoS One       Date:  2018-11-09       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.